A white paper: US biosimilars market on pace with Europe von Feldman, Madelaine, Reilly, Michael S

Volltext

European prescribers’ attitudes and beliefs on biologicals prescribing and automatic substitution von Feldman, Madelaine, Reilly, Michael S

Volltext

Policy recommendations for a sustainable biosimilars market: lessons from Europe von Schneider, Philip J, Reilly, Michael S

Volltext

Key factors for successful uptake of biosimilars: Europe and the US von Reilly, Michael S

Volltext

US prescribers’ attitudes and perceptions about biosimilars von Reilly, Michael S, McKibbin, Ralph D

Volltext

A critical review of substitution policy for biosimilars in Canada von Reilly, Michael S, Schneider, Philip J

Volltext

Non-medical switching of biologicals/biosimilars: Canada, Europe and the US – a webinar report von Reilly, Michael S, Attara, Gail, McKibbin, Ralph D, Schneider, Philip J

Volltext

Medicare drug price negotiations: impact on healthcare development and patient access to medicines von Reilly, Michael S, Barker, Thomas R, Clapton, Charles M, Potts, Steven J, Spiegel, Andrew

Volltext

Biosimilars naming, label transparency and authority of choice – survey findings among European physicians von Dolinar, Richard O, Reilly, Michael S

Volltext

A survey of Australian prescribers’ views on the naming and substitution of biologicals von Murby, Stephen P, Reilly, Michael S

Volltext

Medicines regulation in the MENA region and the importance of the World Health Organization’s INN proposal of Biological Qualifier von Pitts, Peter J, Reilly, Michael S

Volltext

Prescribing practices for biosimilars: questionnaire survey findings from physicians in Argentina, Brazil, Colombia and Mexico von Reilly, Michael S, Gewanter, Harry L

Volltext

Naming and labelling of biologicals – a survey of US physicians’ perspectives von Gewanter, Harry L, Reilly, Michael S

Volltext

Naming and labelling of biologicals – the perspective of hospital and retail pharmacists von Schneider, Philip J, Reilly, Michael S

Volltext

Preserve the US interchangeable standard that has helped drive physician and patient confidence in biosimilars von Reilly, Michael S

Volltext

Preserve the US interchangeable standard that has helped drive physician and patient confidence in biosimilars von Reilly, Michael S

Volltext

The future of biological therapy: a pathway forward for biosimilars von Dolinar, Richard O, Reilly, Michael S

Volltext

US prescribers' attitudes and perceptions about biosimilars von Reilly, Michael S

Volltext

Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars von Reilly, Michael S, Barratt, Jane

Volltext

Canadian prescribers' attitudes and perceptions about ophthalmic biosimilars von Reilly, Michael S, Barratt, Jane

Volltext